This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Dermatology
Fumaric acid esters effective in children with moderate to severe psoriasis
Read more
Tele-health seen as time-efficient during COVID-19 according to those with skin conditions
Read more
Topical steroids normalise inflammatory markers in infants with atopic eczema
Read more
Uncertainty over the efficacy of up-dosing antihistamine in chronic urticaria
Read more
Live-bacterial spray improves disease severity in children with atopic eczema
Read more
Tape-stripping identifies a distinct biomarker to differentiate eczema from psoriasis
Read more
Cosentyx® receives EU approval as first-line system for paediatric psoriasis
Read more
Still no effective treatment for patients with CLE
Read more
JAK inhibitors: a major advance in the treatment of atopic eczema
Read more
Text message reminders have little impact on sun protection habits
Read more
IL-17 a potential therapeutic target in chronic urticaria
Read more
Can daily application of an emollient from birth prevent the development of atopic eczema?
Read more
Expert view: Sunbed use and melanoma – is there really a link?
Read more
Expert view: Where next for dupilumab?
Read more
Dupilumab approved by EC for adolescents with moderate-to-severe atopic dermatitis
Read more
Multiple genes affect risk of asthma, hay fever and eczema
Read more
Common skin bacterium puts children with severe eczema at higher risk of food allergy
Read more
Page 5 of 7
« First
«
...
3
4
5
6
7
»
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: